Cargando…

Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disease of the gastrointestinal tract, associated with high levels of inflammatory cytokine production. Human caspases-4 and -5, and their murine ortholog caspase-11, are essential components of the innate immune pathway, capable o...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Aoife P., Creagh, Emma M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194562/
https://www.ncbi.nlm.nih.gov/pubmed/35712726
http://dx.doi.org/10.3389/fphar.2022.919567
_version_ 1784726757286346752
author Smith, Aoife P.
Creagh, Emma M.
author_facet Smith, Aoife P.
Creagh, Emma M.
author_sort Smith, Aoife P.
collection PubMed
description Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disease of the gastrointestinal tract, associated with high levels of inflammatory cytokine production. Human caspases-4 and -5, and their murine ortholog caspase-11, are essential components of the innate immune pathway, capable of sensing and responding to intracellular lipopolysaccharide (LPS), a component of Gram-negative bacteria. Following their activation by LPS, these caspases initiate potent inflammation by causing pyroptosis, a lytic form of cell death. While this pathway is essential for host defence against bacterial infection, it is also negatively associated with inflammatory pathologies. Caspases-4/-5/-11 display increased intestinal expression during IBD and have been implicated in chronic IBD inflammation. This review discusses the current literature in this area, identifying links between inflammatory caspase activity and IBD in both human and murine models. Differences in the expression and functions of caspases-4, -5 and -11 are discussed, in addition to mechanisms of their activation, function and regulation, and how these mechanisms may contribute to the pathogenesis of IBD.
format Online
Article
Text
id pubmed-9194562
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91945622022-06-15 Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease Smith, Aoife P. Creagh, Emma M. Front Pharmacol Pharmacology Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disease of the gastrointestinal tract, associated with high levels of inflammatory cytokine production. Human caspases-4 and -5, and their murine ortholog caspase-11, are essential components of the innate immune pathway, capable of sensing and responding to intracellular lipopolysaccharide (LPS), a component of Gram-negative bacteria. Following their activation by LPS, these caspases initiate potent inflammation by causing pyroptosis, a lytic form of cell death. While this pathway is essential for host defence against bacterial infection, it is also negatively associated with inflammatory pathologies. Caspases-4/-5/-11 display increased intestinal expression during IBD and have been implicated in chronic IBD inflammation. This review discusses the current literature in this area, identifying links between inflammatory caspase activity and IBD in both human and murine models. Differences in the expression and functions of caspases-4, -5 and -11 are discussed, in addition to mechanisms of their activation, function and regulation, and how these mechanisms may contribute to the pathogenesis of IBD. Frontiers Media S.A. 2022-05-31 /pmc/articles/PMC9194562/ /pubmed/35712726 http://dx.doi.org/10.3389/fphar.2022.919567 Text en Copyright © 2022 Smith and Creagh. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Smith, Aoife P.
Creagh, Emma M.
Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
title Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
title_full Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
title_fullStr Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
title_full_unstemmed Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
title_short Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
title_sort caspase-4 and -5 biology in the pathogenesis of inflammatory bowel disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194562/
https://www.ncbi.nlm.nih.gov/pubmed/35712726
http://dx.doi.org/10.3389/fphar.2022.919567
work_keys_str_mv AT smithaoifep caspase4and5biologyinthepathogenesisofinflammatoryboweldisease
AT creaghemmam caspase4and5biologyinthepathogenesisofinflammatoryboweldisease